Efamet 600 mg (1 pack / 30 tabs)

Efavirenz 600mg (likely the active ingredient in "Efamet") is indicated for the treatment of HIV-1 infection, but in combination with other medications, it can also be used as part of a regimen for the treatment of Hepatitis C virus (HCV) co-infected patients. However, its primary and direct indication is not specifically for HCV alone but rather for HIV. In the context of HCV treatment, efavirenz might be used off-label or as part of managing co-infection with HIV. The standard treatment for HCV typically involves direct-acting antivirals (DAAs).